Drug Shortage Report for MYLAN-RIVASTIGMINE PATCH 10
Report ID | 193436 |
Drug Identification Number | 02423421 |
Brand name | MYLAN-RIVASTIGMINE PATCH 10 |
Common or Proper name | RIVASTIGMINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RIVASTIGMINE |
Strength(s) | 9.5MG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 30 Patches |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-05-31 |
Estimated end date | 2023-06-30 |
Actual end date | 2023-06-29 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-10-03 | French | Compare |
v9 | 2023-10-03 | English | Compare |
v8 | 2023-06-27 | French | Compare |
v7 | 2023-06-27 | English | Compare |
v6 | 2023-06-21 | French | Compare |
v5 | 2023-06-21 | English | Compare |
v4 | 2023-06-13 | French | Compare |
v3 | 2023-06-13 | English | Compare |
v2 | 2023-05-31 | French | Compare |
v1 | 2023-05-31 | English | Compare |
Showing 1 to 10 of 10